| Year |
Citation |
Score |
| 2014 |
Pereira M, Pfisterer U, Rylander D, Torper O, Lau S, Lundblad M, Grealish S, Parmar M. Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain. Scientific Reports. 4: 6330. PMID 25208484 DOI: 10.1038/Srep06330 |
0.579 |
|
| 2013 |
Rylander D, Bagetta V, Pendolino V, Zianni E, Grealish S, Gardoni F, Di Luca M, Calabresi P, Cenci MA, Picconi B. Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. 110: E4375-84. PMID 24170862 DOI: 10.1073/Pnas.1311187110 |
0.371 |
|
| 2013 |
Rylander D. Restoration of synaptic plasticity in the host striatum: can transplants make it? Neuroreport. 24: 1016-8. PMID 24152765 DOI: 10.1097/Wnr.0000000000000061 |
0.399 |
|
| 2013 |
Iderberg H, Rylander D, Bimpisidis Z, Cenci MA. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action. Experimental Neurology. 250: 116-24. PMID 24029003 DOI: 10.1016/J.Expneurol.2013.09.003 |
0.71 |
|
| 2013 |
Rylander D, Lindgren HS. The serotonergic component in Parkinson's disease symptoms and therapy side-effects Serotonergic Systems: Evolution, Functions and Roles in Disease. 107-129. |
0.572 |
|
| 2012 |
Rylander D. The serotonin system: a potential target for anti-dyskinetic treatments and biomarker discovery. Parkinsonism & Related Disorders. 18: S126-8. PMID 22166409 DOI: 10.1016/S1353-8020(11)70039-6 |
0.501 |
|
| 2011 |
Lindgren HS, Rylander D, Iderberg H, Andersson M, O'Sullivan SS, Williams DR, Lees AJ, Cenci MA. Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia. Journal of Parkinson's Disease. 1: 347-57. PMID 23933656 DOI: 10.3233/Jpd-2011-11068 |
0.624 |
|
| 2010 |
Rylander D, Parent M, O'Sullivan SS, Dovero S, Lees AJ, Bezard E, Descarries L, Cenci MA. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Annals of Neurology. 68: 619-28. PMID 20882603 DOI: 10.1002/Ana.22097 |
0.433 |
|
| 2010 |
Malmlöf T, Rylander D, Alken RG, Schneider F, Svensson TH, Cenci MA, Schilström B. Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias. Experimental Neurology. 225: 408-15. PMID 20659451 DOI: 10.1016/J.Expneurol.2010.07.018 |
0.591 |
|
| 2010 |
Rylander D, Iderberg H, Li Q, Dekundy A, Zhang J, Li H, Baishen R, Danysz W, Bezard E, Cenci MA. A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiology of Disease. 39: 352-61. PMID 20452425 DOI: 10.1016/J.Nbd.2010.05.001 |
0.729 |
|
| 2009 |
Cenci MA, Ohlin KE, Rylander D. Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia. Parkinsonism & Related Disorders. 15: S59-63. PMID 20083009 DOI: 10.1016/S1353-8020(09)70782-5 |
0.513 |
|
| 2009 |
Rylander D, Recchia A, Mela F, Dekundy A, Danysz W, Cenci MA. Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling. The Journal of Pharmacology and Experimental Therapeutics. 330: 227-35. PMID 19357321 DOI: 10.1124/Jpet.108.150425 |
0.544 |
|
| 2009 |
Schuster S, Doudnikoff E, Rylander D, Berthet A, Aubert I, Ittrich C, Bloch B, Cenci MA, Surmeier DJ, Hengerer B, Bezard E. Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biological Psychiatry. 65: 518-26. PMID 18947822 DOI: 10.1016/J.Biopsych.2008.09.008 |
0.633 |
|
| 2009 |
Rylander D, Li Q, Dekundy A, Li H, Baishen R, Danysz W, Bezard E, Cenci A. P2.157 Metabotropic glutamate receptor type 5 (mGluR5) antagonists improve L-DOPA-induced-dyskinesia in both rat and macaque models of Parkinson's disease Parkinsonism & Related Disorders. 15: S132. DOI: 10.1016/S1353-8020(09)70508-5 |
0.551 |
|
| 2007 |
Lindgren HS, Rylander D, Ohlin KE, Lundblad M, Cenci MA. The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration. Behavioural Brain Research. 177: 150-9. PMID 17157933 DOI: 10.1016/J.Bbr.2006.09.019 |
0.739 |
|
| 2007 |
Rylander D, Strome E, Mela F, Mercanti G, Cenci M. 2.506 The severity of L-DOPA-induced dyskinesia in the rat is positively correlated with the density of striatal serotonin afferents Parkinsonism & Related Disorders. 13: S144. DOI: 10.1016/S1353-8020(08)70780-6 |
0.438 |
|
| 2007 |
Rylander D, Strome E, Mela F, Mercanti G, Cenci M. 2.016 The severity of L-DOPA-induced dyskinesia in the rat is positively correlated with the density of striatal serotonin afferents Parkinsonism & Related Disorders. 13: S90. DOI: 10.1016/S1353-8020(08)70584-4 |
0.52 |
|
| Show low-probability matches. |